Are Peptides Coming By End Of Year?

<p>Thanks to our partners:</p><p>Superpower - https://superpower.com</p><p>CareValidate - https://carevalidate.com</p><p><br></p><p>In episode 83, Jonathan Stern talks with Scott Brunner, CEO of the Alliance for Pharmacy Compounding, the trade group for more than 600 compounding businesses, about the WaPo report that the administration may let pharmacies sell certain peptides before a formal rule is finished. Brunner says he thinks an announcement is &quot;highly likely&quot; before EOY, and he wants conditions on it: ingredients only from FDA-registered wholesalers, a clearer warning to patients, and reports of serious side effects.</p><p><br></p><p>00:00 - Sponsors </p><p>01:22 - Peptides may be &quot;imminent&quot;</p><p>09:36 - The guardrails the Scott is advocating for </p><p>14:00 - RFK is driving this through</p><p>19:26 - Pharmacies may need 2-3 months to get ready</p><p>23:08 - Which peptides would be included? </p><p>25:57 - What about 503B facilities? </p><p>28:22 - How long formal rulemaking takes</p><p>30:45 - U.S. peptide API capacity will take time </p><p>32:56 - Future of the gray market</p><p>35:52 - The Empower warning letter and future of compounded GLP-1s </p><p>39:28 - Congressional bills Scott is watching</p><p><br></p><p><em>Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions. </em></p>